OBJECTIVE: The aim of this study was to determine whether adherence to self-care modalities for breast cancer-related lymphedema (BCRL) predicts BCRL outcomes among 128 breast cancer survivors who participated in the 12-mo physical activity and lymphedema trial. DESIGN: This was a prospective cohort study. Adherence to ten BCRL self-care modalities, as recommended in the clinical practice guidelines for the management of BCRL, was assessed by a questionnaire at baseline. BCRL outcomes assessed at baseline and 12 mos included volumetry, circumferences, bioimpedence spectroscopy, the Norman lymphedema survey, and therapist-defined lymphedema exacerbations requiring treatment. Generalized linear models were used to estimate the relationship between adherence to BCRL self-care modalities and the likelihood of experiencing a BCRL outcome. RESULTS: Adherence to BCRL self-care activities did not predict experiencing any BCRL outcomes at 12 mos. Levels of adherence to BCRL self-care modalities did not predict a 5% or greater decrease in interlimb volume (Ptrend = 0.79), 5% or greater decrease in the sum of interlimb arm circumferences (Ptrend = 0.47), 10% or greater decrease in bioimpedence spectroscopy (Ptrend = 0.83), 1 or greater decrease in self-reported lymphedema symptoms (Ptrend = 0.91), or therapist-defined lymphedema exacerbation requiring treatment (Ptrend = 0.84). CONCLUSIONS: Our findings suggest that levels of BCRL self-care adherence do not predict BCRL outcomes among breast cancer survivors with stable lymphedema who were followed for 12 mos.
RCT Entities:
OBJECTIVE: The aim of this study was to determine whether adherence to self-care modalities for breast cancer-related lymphedema (BCRL) predicts BCRL outcomes among 128 breast cancer survivors who participated in the 12-mo physical activity and lymphedema trial. DESIGN: This was a prospective cohort study. Adherence to ten BCRL self-care modalities, as recommended in the clinical practice guidelines for the management of BCRL, was assessed by a questionnaire at baseline. BCRL outcomes assessed at baseline and 12 mos included volumetry, circumferences, bioimpedence spectroscopy, the Norman lymphedema survey, and therapist-defined lymphedema exacerbations requiring treatment. Generalized linear models were used to estimate the relationship between adherence to BCRL self-care modalities and the likelihood of experiencing a BCRL outcome. RESULTS: Adherence to BCRL self-care activities did not predict experiencing any BCRL outcomes at 12 mos. Levels of adherence to BCRL self-care modalities did not predict a 5% or greater decrease in interlimb volume (Ptrend = 0.79), 5% or greater decrease in the sum of interlimb arm circumferences (Ptrend = 0.47), 10% or greater decrease in bioimpedence spectroscopy (Ptrend = 0.83), 1 or greater decrease in self-reported lymphedema symptoms (Ptrend = 0.91), or therapist-defined lymphedema exacerbation requiring treatment (Ptrend = 0.84). CONCLUSIONS: Our findings suggest that levels of BCRL self-care adherence do not predict BCRL outcomes among breast cancer survivors with stable lymphedema who were followed for 12 mos.
Authors: Sheila H Ridner; Mei R Fu; Ausanee Wanchai; Bob R Stewart; Jane M Armer; Janice N Cormier Journal: Nurs Res Date: 2012 Jul-Aug Impact factor: 2.381
Authors: Justin C Brown; Andrea L Cheville; Julia C Tchou; Susan R Harris; Kathryn H Schmitz Journal: Support Care Cancer Date: 2013-09-07 Impact factor: 3.603
Authors: Sandra C Hayes; Rebecca M Speck; Elizabeth Reimet; Azadeh Stark; Kathryn H Schmitz Journal: Breast Cancer Res Treat Date: 2011-05-12 Impact factor: 4.872
Authors: Lorraine T Dean; Anagha Kumar; Taehoon Kim; Matthew Herling; Justin C Brown; Zi Zhang; Margaret Evangelisti; Renata Hackley; Jiyoung Kim; Andrea Cheville; Andrea B Troxel; J Sanford Schwartz; Kathryn H Schmitz Journal: J Obes Date: 2016-06-28
Authors: Stanley G Rockson; Pinar Karaca-Mandic; Roman Skoracki; Karen Hock; Michelle Nguyen; Kristin Shadduck; Phyllis Gingerich; Elizabeth Campione; Andrea Leifer; Jane Armer Journal: Lymphat Res Biol Date: 2021-07-02 Impact factor: 2.349